Concepedia

Juraj Ahel

JA

Statistics

Publications

5

Citations

292

H-Index

5

Active since

2020

Affiliations

Research Institute of Molecular Pathology(Current)

Vienna BioCenter Core Facilities

Medical University of Vienna

Vienna Biocenter

Institute of Molecular Biotechnology

Juraj Ahel is an author at Research Institute of Molecular Pathology specializing in life sciences, molecular biology, and regulation by e3 ubiquitin ligases.

ORCID

Publications per year

2020–2025

5

Publications

5

Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism

Juraj Ahel, Anita Lehner, Antonia Vogel et al. · eLife · 2020 · 144 citations · Full text

, , +15

HUWE1 employs a giant substrate-binding ring to feed and regulate its HECT E3 domain

Daniel B. Grabarczyk, Olga A. Petrova, Luiza Deszcz et al. · Nature Chemical Biology · 2021 · 55 citations · Full text

, , +13

PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation

Pulak Kar, Chatrin Chatrin, Nina Đukić et al. · The EMBO Journal · 2024 · 55 citations · Full text

, , +7

E3 ubiquitin ligase RNF213 employs a non-canonical zinc finger active site and is allosterically regulated by ATP

Juraj Ahel, Adam J. Fletcher, Daniel B. Grabarczyk et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 27 citations · Full text

, , +13

ATP functions as a pathogen-associated molecular pattern to activate the E3 ubiquitin ligase RNF213

Juraj Ahel, Arda Balci, Victoria Faas et al. · Nature Communications · 2025 · 11 citations · Full text

, , +15

1–5 of 5